Key facts
- Arfysica Innovation’s last known valuation is $86.5M (Apr 2022).
- It has raised $7.9M; the latest was Later Stage VC in Feb 2026.
- Notable investors include Oriental Fortune Capital, Shenzhen Guozhong Venture Capital Management, Acorn Partners, Shanghai Daohe Long Term Investment Management, Shenzhen Antuo Investment Management — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Arfysica Innovation
- ·The full record, as it builds
Funding rounds
No funding rounds for Arfysica Innovation are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Arfysica Innovation
Developer of digital 3D printing technology and solutions intended for clinical diagnosis and medical treatment. The company offers human multimodal data and artificial intelligence (AI) technology, serving clinical industries to optimize resource utilization and leverage data to achieve a healthier life.
- Sector
- Healthcare
- HQ
- Shanghai, China
- Founded
- 2015
- Ownership
- Privately Held (backing)
Arfysica Innovation doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Arfysica Innovation shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Arfysica Innovation in its N-PORT filings yet. We sweep new filings monthly.